Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.403343396211244.
The log-likelihood improved by 3.393.
Iteration 2 of at most 500:
Optimizing with step length 0.965362479651954.
The log-likelihood improved by 2.677.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.3977.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 1.08.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       2       23     1325     1082      807      325      376      328 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     264      187      140       65       44       19       10        2 
degree17 
       1 
1 
disease_progression 
H-positive risk:  881 890 131 876 409 113 888 448 109 66 119 70 
H-negative risk:  890 881 888 876 448 409 113 131 119 109 70 66 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
58 new agents 
2 
disease_progression 
H-positive risk:  887 899 134 869 403 115 889 444 106 66 119 69 
H-negative risk:  899 887 889 869 444 403 115 134 119 106 69 66 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
59 new agents 
3 
disease_progression 
H-positive risk:  893 903 135 867 407 116 890 435 104 66 118 66 
H-negative risk:  903 893 890 867 435 407 116 135 118 104 66 66 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 3 

clinical_engagement 
diagnosis 
demography 
71 new agents 
4 
disease_progression 
H-positive risk:  898 907 135 864 410 116 893 426 103 65 117 66 
H-negative risk:  907 898 893 864 426 410 116 135 117 103 66 65 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 7 

clinical_engagement 
diagnosis 
demography 
74 new agents 
5 
disease_progression 
H-positive risk:  904 911 136 866 407 117 885 423 105 65 116 65 
H-negative risk:  911 904 885 866 423 407 117 136 116 105 65 65 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 7 

clinical_engagement 
diagnosis 
demography 
46 new agents 
6 
disease_progression 
H-positive risk:  906 919 135 867 406 117 881 419 107 65 114 64 
H-negative risk:  919 906 881 867 419 406 117 135 114 107 64 65 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 9 

clinical_engagement 
diagnosis 
demography 
79 new agents 
7 
disease_progression 
H-positive risk:  905 915 136 869 398 121 887 416 111 65 114 63 
H-negative risk:  915 905 887 869 416 398 121 136 114 111 63 65 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 10 

clinical_engagement 
diagnosis 
demography 
55 new agents 
8 
disease_progression 
H-positive risk:  906 922 137 866 397 121 884 410 112 65 115 65 
H-negative risk:  922 906 884 866 410 397 121 137 115 112 65 65 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 13 

clinical_engagement 
diagnosis 
demography 
60 new agents 
9 
disease_progression 
H-positive risk:  911 924 136 870 389 123 885 404 112 67 113 66 
H-negative risk:  924 911 885 870 404 389 123 136 113 112 66 67 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 14 

clinical_engagement 
diagnosis 
demography 
70 new agents 
10 
disease_progression 
H-positive risk:  914 931 138 860 383 124 885 401 117 68 114 65 
H-negative risk:  931 914 885 860 401 383 124 138 114 117 65 68 
New BC onsets:  19
BC status:  4981 19 
BC subtype:  4981 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
11 
disease_progression 
H-positive risk:  919 935 139 862 383 122 888 401 114 62 110 65 
H-negative risk:  935 919 888 862 401 383 122 139 110 114 65 62 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 19 1 

clinical_engagement 
diagnosis 
demography 
64 new agents 
12 
disease_progression 
H-positive risk:  925 939 139 862 387 123 883 394 115 59 110 64 
H-negative risk:  939 925 883 862 394 387 123 139 110 115 64 59 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 19 1 

clinical_engagement 
diagnosis 
demography 
51 new agents 
13 
disease_progression 
H-positive risk:  847 847 132 959 379 114 961 394 126 60 118 63 
H-negative risk:  847 847 961 959 394 379 114 132 118 126 63 60 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 22 2 

clinical_engagement 
diagnosis 
demography 
222 new agents 
14 
disease_progression 
H-positive risk:  877 878 138 908 403 116 902 422 117 66 114 59 
H-negative risk:  878 877 902 908 422 403 116 138 114 117 59 66 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 24 9 

clinical_engagement 
diagnosis 
demography 
55 new agents 
15 
disease_progression 
H-positive risk:  882 881 139 915 397 116 898 417 119 62 117 57 
H-negative risk:  881 882 898 915 417 397 116 139 117 119 57 62 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 25 11 

clinical_engagement 
diagnosis 
demography 
57 new agents 
16 
disease_progression 
H-positive risk:  877 887 138 912 397 117 901 415 119 63 118 56 
H-negative risk:  887 877 901 912 415 397 117 138 118 119 56 63 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 29 11 

clinical_engagement 
diagnosis 
demography 
60 new agents 
17 
disease_progression 
H-positive risk:  888 896 139 904 389 117 901 416 119 61 117 53 
H-negative risk:  896 888 901 904 416 389 117 139 117 119 53 61 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 30 12 

clinical_engagement 
diagnosis 
demography 
55 new agents 
18 
disease_progression 
H-positive risk:  894 895 142 911 383 120 896 411 115 62 118 53 
H-negative risk:  895 894 896 911 411 383 120 142 118 115 53 62 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 31 12 

clinical_engagement 
diagnosis 
demography 
60 new agents 
19 
disease_progression 
H-positive risk:  896 891 142 919 380 123 902 407 115 59 116 50 
H-negative risk:  891 896 902 919 407 380 123 142 116 115 50 59 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 30 13 

clinical_engagement 
diagnosis 
demography 
68 new agents 
20 
disease_progression 
H-positive risk:  904 887 143 927 371 125 897 402 116 60 116 52 
H-negative risk:  887 904 897 927 402 371 125 143 116 116 52 60 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 31 13 

clinical_engagement 
diagnosis 
demography 
48 new agents 
21 
disease_progression 
H-positive risk:  909 890 146 925 370 124 889 402 117 60 116 52 
H-negative risk:  890 909 889 925 402 370 124 146 116 117 52 60 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 32 13 

clinical_engagement 
diagnosis 
demography 
63 new agents 
22 
disease_progression 
H-positive risk:  909 894 144 927 373 122 893 398 115 60 115 50 
H-negative risk:  894 909 893 927 398 373 122 144 115 115 50 60 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 33 14 

clinical_engagement 
diagnosis 
demography 
65 new agents 
23 
disease_progression 
H-positive risk:  912 895 146 920 374 124 892 396 115 62 116 48 
H-negative risk:  895 912 892 920 396 374 124 146 116 115 48 62 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 39 13 

clinical_engagement 
diagnosis 
demography 
63 new agents 
24 
disease_progression 
H-positive risk:  919 904 146 921 369 124 887 389 116 63 115 47 
H-negative risk:  904 919 887 921 389 369 124 146 115 116 47 63 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 39 13 

clinical_engagement 
diagnosis 
demography 
55 new agents 
25 
disease_progression 
H-positive risk:  857 832 136 1002 365 111 954 384 128 61 124 46 
H-negative risk:  832 857 954 1002 384 365 111 136 124 128 46 61 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 40 13 

clinical_engagement 
diagnosis 
demography 
180 new agents 
26 
disease_progression 
H-positive risk:  880 849 137 962 383 113 916 409 124 65 113 49 
H-negative risk:  849 880 916 962 409 383 113 137 113 124 49 65 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 43 13 

clinical_engagement 
diagnosis 
demography 
75 new agents 
27 
disease_progression 
H-positive risk:  888 856 136 957 378 113 918 404 123 64 116 47 
H-negative risk:  856 888 918 957 404 378 113 136 116 123 47 64 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 43 13 

clinical_engagement 
diagnosis 
demography 
64 new agents 
28 
disease_progression 
H-positive risk:  894 854 136 955 375 113 918 405 123 65 115 47 
H-negative risk:  854 894 918 955 405 375 113 136 115 123 47 65 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 44 15 

clinical_engagement 
diagnosis 
demography 
51 new agents 
29 
disease_progression 
H-positive risk:  900 853 137 961 368 111 917 408 122 63 114 46 
H-negative risk:  853 900 917 961 408 368 111 137 114 122 46 63 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 46 15 

clinical_engagement 
diagnosis 
demography 
53 new agents 
30 
disease_progression 
H-positive risk:  893 858 135 963 366 112 922 403 122 64 116 46 
H-negative risk:  858 893 922 963 403 366 112 135 116 122 46 64 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 46 18 

clinical_engagement 
diagnosis 
demography 
57 new agents 
31 
disease_progression 
H-positive risk:  893 859 135 971 367 114 919 397 123 64 115 43 
H-negative risk:  859 893 919 971 397 367 114 135 115 123 43 64 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 45 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
32 
disease_progression 
H-positive risk:  901 856 135 973 366 113 914 394 127 63 115 43 
H-negative risk:  856 901 914 973 394 366 113 135 115 127 43 63 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 41 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
33 
disease_progression 
H-positive risk:  910 862 136 967 361 112 911 394 127 64 113 43 
H-negative risk:  862 910 911 967 394 361 112 136 113 127 43 64 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 40 22 

clinical_engagement 
diagnosis 
demography 
55 new agents 
34 
disease_progression 
H-positive risk:  909 865 135 972 356 114 912 394 123 66 112 42 
H-negative risk:  865 909 912 972 394 356 114 135 112 123 42 66 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 42 21 

clinical_engagement 
diagnosis 
demography 
56 new agents 
35 
disease_progression 
H-positive risk:  913 872 135 963 362 114 913 387 122 66 112 41 
H-negative risk:  872 913 913 963 387 362 114 135 112 122 41 66 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 43 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
36 
disease_progression 
H-positive risk:  909 879 137 961 353 116 921 380 124 65 115 40 
H-negative risk:  879 909 921 961 380 353 116 137 115 124 40 65 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 43 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
37 
disease_progression 
H-positive risk:  859 832 124 1012 348 110 974 376 131 62 131 41 
H-negative risk:  832 859 974 1012 376 348 110 124 131 131 41 62 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 43 22 

clinical_engagement 
diagnosis 
demography 
143 new agents 
38 
disease_progression 
H-positive risk:  874 842 128 994 362 111 921 406 125 65 127 45 
H-negative risk:  842 874 921 994 406 362 111 128 127 125 45 65 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 46 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
39 
disease_progression 
H-positive risk:  880 842 127 999 357 112 924 401 123 65 127 43 
H-negative risk:  842 880 924 999 401 357 112 127 127 123 43 65 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 48 21 

clinical_engagement 
diagnosis 
demography 
50 new agents 
40 
disease_progression 
H-positive risk:  887 836 130 1003 359 112 911 405 121 65 128 43 
H-negative risk:  836 887 911 1003 405 359 112 130 128 121 43 65 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 52 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
41 
disease_progression 
H-positive risk:  890 839 127 1011 362 111 897 404 122 64 131 42 
H-negative risk:  839 890 897 1011 404 362 111 127 131 122 42 64 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 53 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
42 
disease_progression 
H-positive risk:  889 841 126 1005 364 111 902 396 122 65 136 43 
H-negative risk:  841 889 902 1005 396 364 111 126 136 122 43 65 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 52 20 

clinical_engagement 
diagnosis 
demography 
49 new agents 
43 
disease_progression 
H-positive risk:  886 845 127 1005 359 109 906 393 124 65 140 41 
H-negative risk:  845 886 906 1005 393 359 109 127 140 124 41 65 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 54 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
44 
disease_progression 
H-positive risk:  887 846 129 998 361 113 906 391 125 65 140 39 
H-negative risk:  846 887 906 998 391 361 113 129 140 125 39 65 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 54 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
45 
disease_progression 
H-positive risk:  891 852 130 985 358 116 909 388 125 62 143 41 
H-negative risk:  852 891 909 985 388 358 116 130 143 125 41 62 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 53 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
46 
disease_progression 
H-positive risk:  894 855 130 979 353 114 912 390 128 63 141 41 
H-negative risk:  855 894 912 979 390 353 114 130 141 128 41 63 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 53 25 

clinical_engagement 
diagnosis 
demography 
58 new agents 
47 
disease_progression 
H-positive risk:  897 856 126 980 352 114 910 387 127 63 146 42 
H-negative risk:  856 897 910 980 387 352 114 126 146 127 42 63 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 52 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
48 
disease_progression 
H-positive risk:  899 863 125 980 347 113 909 382 129 64 145 44 
H-negative risk:  863 899 909 980 382 347 113 125 145 129 44 64 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 53 25 

clinical_engagement 
diagnosis 
demography 
48 new agents 
49 
disease_progression 
H-positive risk:  831 807 117 1037 346 104 974 381 139 60 158 46 
H-negative risk:  807 831 974 1037 381 346 104 117 158 139 46 60 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 57 25 

clinical_engagement 
diagnosis 
demography 
137 new agents 
50 
disease_progression 
H-positive risk:  834 809 121 1007 364 105 960 393 140 64 155 48 
H-negative risk:  809 834 960 1007 393 364 105 121 155 140 48 64 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 56 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
51 
disease_progression 
H-positive risk:  838 818 124 1004 360 105 955 393 136 65 158 44 
H-negative risk:  818 838 955 1004 393 360 105 124 158 136 44 65 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 57 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
52 
disease_progression 
H-positive risk:  842 813 124 1001 361 105 956 399 135 63 158 43 
H-negative risk:  813 842 956 1001 399 361 105 124 158 135 43 63 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 57 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
53 
disease_progression 
H-positive risk:  843 814 123 1000 364 105 956 395 139 61 158 42 
H-negative risk:  814 843 956 1000 395 364 105 123 158 139 42 61 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 54 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
54 
disease_progression 
H-positive risk:  848 814 125 998 365 106 950 392 140 63 158 41 
H-negative risk:  814 848 950 998 392 365 106 125 158 140 41 63 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 54 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
55 
disease_progression 
H-positive risk:  850 814 124 1003 364 106 949 393 139 61 156 41 
H-negative risk:  814 850 949 1003 393 364 106 124 156 139 41 61 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 55 24 

clinical_engagement 
diagnosis 
demography 
59 new agents 
56 
disease_progression 
H-positive risk:  855 818 124 995 363 105 952 392 139 62 156 39 
H-negative risk:  818 855 952 995 392 363 105 124 156 139 39 62 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 55 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
57 
disease_progression 
H-positive risk:  859 815 125 1000 365 107 951 387 138 62 152 39 
H-negative risk:  815 859 951 1000 387 365 107 125 152 138 39 62 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 57 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
58 
disease_progression 
H-positive risk:  871 816 128 998 358 109 948 383 137 61 154 37 
H-negative risk:  816 871 948 998 383 358 109 128 154 137 37 61 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 57 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
59 
disease_progression 
H-positive risk:  871 818 129 996 356 110 953 380 140 57 153 37 
H-negative risk:  818 871 953 996 380 356 110 129 153 140 37 57 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 58 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
60 
disease_progression 
H-positive risk:  872 826 134 994 360 112 953 378 135 54 146 36 
H-negative risk:  826 872 953 994 378 360 112 134 146 135 36 54 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 59 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
61 
disease_progression 
H-positive risk:  818 776 124 1044 365 104 1005 376 140 55 155 38 
H-negative risk:  776 818 1005 1044 376 365 104 124 155 140 38 55 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 62 26 

clinical_engagement 
diagnosis 
demography 
111 new agents 
62 
disease_progression 
H-positive risk:  826 773 126 1022 392 106 983 383 138 58 153 40 
H-negative risk:  773 826 983 1022 383 392 106 126 153 138 40 58 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 59 27 

clinical_engagement 
diagnosis 
demography 
91 new agents 
63 
disease_progression 
H-positive risk:  827 780 119 1026 389 103 982 379 136 60 156 43 
H-negative risk:  780 827 982 1026 379 389 103 119 156 136 43 60 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 61 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
64 
disease_progression 
H-positive risk:  824 792 118 1025 390 103 984 369 135 61 156 43 
H-negative risk:  792 824 984 1025 369 390 103 118 156 135 43 61 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 63 25 

clinical_engagement 
diagnosis 
demography 
53 new agents 
65 
disease_progression 
H-positive risk:  821 789 117 1025 388 101 994 370 137 58 154 46 
H-negative risk:  789 821 994 1025 370 388 101 117 154 137 46 58 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 63 28 

clinical_engagement 
diagnosis 
demography 
69 new agents 
66 
disease_progression 
H-positive risk:  817 786 115 1025 384 100 991 376 140 60 157 49 
H-negative risk:  786 817 991 1025 376 384 100 115 157 140 49 60 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 63 28 

clinical_engagement 
diagnosis 
demography 
81 new agents 
67 
disease_progression 
H-positive risk:  814 799 113 1024 382 96 995 371 142 59 157 48 
H-negative risk:  799 814 995 1024 371 382 96 113 157 142 48 59 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 63 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
68 
disease_progression 
H-positive risk:  810 802 114 1025 381 96 998 370 140 61 156 47 
H-negative risk:  802 810 998 1025 370 381 96 114 156 140 47 61 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 61 28 

clinical_engagement 
diagnosis 
demography 
64 new agents 
69 
disease_progression 
H-positive risk:  814 804 114 1023 379 96 1002 365 135 62 156 50 
H-negative risk:  804 814 1002 1023 365 379 96 114 156 135 50 62 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 63 26 

clinical_engagement 
diagnosis 
demography 
61 new agents 
70 
disease_progression 
H-positive risk:  818 802 116 1024 377 98 1006 359 135 65 154 46 
H-negative risk:  802 818 1006 1024 359 377 98 116 154 135 46 65 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 65 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
71 
disease_progression 
H-positive risk:  817 806 115 1028 366 98 1008 355 135 65 159 48 
H-negative risk:  806 817 1008 1028 355 366 98 115 159 135 48 65 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 66 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
72 
disease_progression 
H-positive risk:  816 797 112 1037 365 101 1010 353 136 64 161 48 
H-negative risk:  797 816 1010 1037 353 365 101 112 161 136 48 64 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 67 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
73 
disease_progression 
H-positive risk:  769 748 106 1086 357 93 1065 354 145 63 168 46 
H-negative risk:  748 769 1065 1086 354 357 93 106 168 145 46 63 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
121 new agents 
74 
disease_progression 
H-positive risk:  771 761 104 1078 355 94 1053 360 142 63 168 51 
H-negative risk:  761 771 1053 1078 360 355 94 104 168 142 51 63 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 68 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
75 
disease_progression 
H-positive risk:  774 768 103 1077 365 95 1037 362 144 60 167 48 
H-negative risk:  768 774 1037 1077 362 365 95 103 167 144 48 60 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 67 28 

clinical_engagement 
diagnosis 
demography 
64 new agents 
76 
disease_progression 
H-positive risk:  774 774 99 1078 361 96 1029 370 148 58 166 47 
H-negative risk:  774 774 1029 1078 370 361 96 99 166 148 47 58 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 66 27 

clinical_engagement 
diagnosis 
demography 
59 new agents 
77 
disease_progression 
H-positive risk:  777 780 102 1073 359 97 1023 373 149 54 167 46 
H-negative risk:  780 777 1023 1073 373 359 97 102 167 149 46 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 67 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
78 
disease_progression 
H-positive risk:  775 780 105 1068 352 95 1031 374 149 57 165 49 
H-negative risk:  780 775 1031 1068 374 352 95 105 165 149 49 57 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 68 27 

clinical_engagement 
diagnosis 
demography 
58 new agents 
79 
disease_progression 
H-positive risk:  774 774 105 1076 356 94 1035 372 146 59 162 47 
H-negative risk:  774 774 1035 1076 372 356 94 105 162 146 47 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 68 30 

clinical_engagement 
diagnosis 
demography 
82 new agents 
80 
disease_progression 
H-positive risk:  776 775 107 1077 356 95 1025 377 146 60 159 47 
H-negative risk:  775 776 1025 1077 377 356 95 107 159 146 47 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 70 30 

clinical_engagement 
diagnosis 
demography 
58 new agents 
81 
disease_progression 
H-positive risk:  771 777 109 1062 360 96 1034 377 147 58 159 50 
H-negative risk:  777 771 1034 1062 377 360 96 109 159 147 50 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 67 31 

clinical_engagement 
diagnosis 
demography 
63 new agents 
82 
disease_progression 
H-positive risk:  773 783 109 1057 356 96 1041 375 149 57 155 49 
H-negative risk:  783 773 1041 1057 375 356 96 109 155 149 49 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 65 31 

clinical_engagement 
diagnosis 
demography 
65 new agents 
83 
disease_progression 
H-positive risk:  773 784 109 1063 354 94 1042 374 148 57 154 48 
H-negative risk:  784 773 1042 1063 374 354 94 109 154 148 48 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 67 29 

clinical_engagement 
diagnosis 
demography 
86 new agents 
84 
disease_progression 
H-positive risk:  780 785 106 1060 354 94 1039 371 152 55 156 48 
H-negative risk:  785 780 1039 1060 371 354 94 106 156 152 48 55 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 67 29 

clinical_engagement 
diagnosis 
demography 
61 new agents 
85 
disease_progression 
H-positive risk:  734 743 101 1097 357 94 1083 371 152 57 162 49 
H-negative risk:  743 734 1083 1097 371 357 94 101 162 152 49 57 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 67 28 

clinical_engagement 
diagnosis 
demography 
99 new agents 
86 
disease_progression 
H-positive risk:  742 739 101 1079 373 87 1068 391 158 54 158 50 
H-negative risk:  739 742 1068 1079 391 373 87 101 158 158 50 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 66 32 

clinical_engagement 
diagnosis 
demography 
74 new agents 
87 
disease_progression 
H-positive risk:  743 738 102 1075 380 89 1067 389 158 51 157 51 
H-negative risk:  738 743 1067 1075 389 380 89 102 157 158 51 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 66 34 

clinical_engagement 
diagnosis 
demography 
59 new agents 
88 
disease_progression 
H-positive risk:  750 743 101 1068 379 91 1066 387 155 52 157 51 
H-negative risk:  743 750 1066 1068 387 379 91 101 157 155 51 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 71 34 

clinical_engagement 
diagnosis 
demography 
75 new agents 
89 
disease_progression 
H-positive risk:  756 747 101 1071 378 91 1063 380 156 51 158 48 
H-negative risk:  747 756 1063 1071 380 378 91 101 158 156 48 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 70 34 

clinical_engagement 
diagnosis 
demography 
62 new agents 
90 
disease_progression 
H-positive risk:  751 750 105 1072 376 95 1064 371 158 50 160 48 
H-negative risk:  750 751 1064 1072 371 376 95 105 160 158 48 50 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 72 35 

clinical_engagement 
diagnosis 
demography 
68 new agents 
91 
disease_progression 
H-positive risk:  754 758 108 1071 377 95 1061 370 154 49 158 45 
H-negative risk:  758 754 1061 1071 370 377 95 108 158 154 45 49 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 73 34 

clinical_engagement 
diagnosis 
demography 
73 new agents 
92 
disease_progression 
H-positive risk:  757 764 107 1046 382 100 1066 372 156 50 155 45 
H-negative risk:  764 757 1066 1046 372 382 100 107 155 156 45 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 71 35 

clinical_engagement 
diagnosis 
demography 
61 new agents 
93 
disease_progression 
H-positive risk:  762 757 105 1046 383 100 1067 368 159 49 162 42 
H-negative risk:  757 762 1067 1046 368 383 100 105 162 159 42 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 70 34 

clinical_engagement 
diagnosis 
demography 
72 new agents 
94 
disease_progression 
H-positive risk:  761 760 101 1040 386 101 1061 376 160 51 161 42 
H-negative risk:  760 761 1061 1040 376 386 101 101 161 160 42 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
71 new agents 
95 
disease_progression 
H-positive risk:  764 763 102 1042 380 98 1061 376 160 52 162 40 
H-negative risk:  763 764 1061 1042 376 380 98 102 162 160 40 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 69 33 

clinical_engagement 
diagnosis 
demography 
66 new agents 
96 
disease_progression 
H-positive risk:  772 762 102 1040 378 98 1063 378 156 52 155 44 
H-negative risk:  762 772 1063 1040 378 378 98 102 155 156 44 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 67 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
97 
disease_progression 
H-positive risk:  733 718 100 1087 379 91 1099 376 161 52 160 44 
H-negative risk:  718 733 1099 1087 376 379 91 100 160 161 44 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 68 33 

clinical_engagement 
diagnosis 
demography 
113 new agents 
98 
disease_progression 
H-positive risk:  724 724 100 1067 383 94 1099 391 159 55 157 47 
H-negative risk:  724 724 1099 1067 391 383 94 100 157 159 47 55 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 67 32 

clinical_engagement 
diagnosis 
demography 
77 new agents 
99 
disease_progression 
H-positive risk:  726 716 98 1071 384 94 1098 398 158 51 156 50 
H-negative risk:  716 726 1098 1071 398 384 94 98 156 158 50 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 69 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
100 
disease_progression 
H-positive risk:  739 723 98 1067 384 97 1089 394 156 50 154 49 
H-negative risk:  723 739 1089 1067 394 384 97 98 154 156 49 50 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 70 30 

clinical_engagement 
diagnosis 
demography 
66 new agents 
101 
disease_progression 
H-positive risk:  728 730 97 1069 381 99 1092 397 153 52 154 48 
H-negative risk:  730 728 1092 1069 397 381 99 97 154 153 48 52 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 71 32 

clinical_engagement 
diagnosis 
demography 
69 new agents 
102 
disease_progression 
H-positive risk:  738 727 95 1073 384 99 1089 383 152 53 155 52 
H-negative risk:  727 738 1089 1073 383 384 99 95 155 152 52 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 72 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
103 
disease_progression 
H-positive risk:  745 727 96 1070 384 99 1083 378 157 53 155 53 
H-negative risk:  727 745 1083 1070 378 384 99 96 155 157 53 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 70 29 

clinical_engagement 
diagnosis 
demography 
73 new agents 
104 
disease_progression 
H-positive risk:  742 729 96 1081 380 98 1083 380 152 54 152 53 
H-negative risk:  729 742 1083 1081 380 380 98 96 152 152 53 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 72 28 

clinical_engagement 
diagnosis 
demography 
63 new agents 
105 
disease_progression 
H-positive risk:  738 730 97 1082 377 99 1084 381 151 54 153 54 
H-negative risk:  730 738 1084 1082 381 377 99 97 153 151 54 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 73 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
106 
disease_progression 
H-positive risk:  743 732 96 1081 376 97 1091 374 149 56 152 53 
H-negative risk:  732 743 1091 1081 374 376 97 96 152 149 53 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 74 28 

clinical_engagement 
diagnosis 
demography 
63 new agents 
107 
disease_progression 
H-positive risk:  737 724 98 1088 378 98 1090 376 148 56 153 54 
H-negative risk:  724 737 1090 1088 376 378 98 98 153 148 54 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 73 30 

clinical_engagement 
diagnosis 
demography 
62 new agents 
108 
disease_progression 
H-positive risk:  733 718 98 1092 379 95 1090 384 151 55 152 53 
H-negative risk:  718 733 1090 1092 384 379 95 98 152 151 53 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 73 30 

clinical_engagement 
diagnosis 
demography 
67 new agents 
109 
disease_progression 
H-positive risk:  696 664 89 1138 383 93 1124 392 156 54 158 53 
H-negative risk:  664 696 1124 1138 392 383 93 89 158 156 53 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
107 new agents 
110 
disease_progression 
H-positive risk:  692 671 91 1113 396 96 1115 404 154 56 160 52 
H-negative risk:  671 692 1115 1113 404 396 96 91 160 154 52 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
111 
disease_progression 
H-positive risk:  689 674 93 1110 400 96 1114 399 154 59 159 53 
H-negative risk:  674 689 1114 1110 399 400 96 93 159 154 53 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
112 
disease_progression 
H-positive risk:  694 677 90 1109 393 96 1119 394 159 57 162 50 
H-negative risk:  677 694 1119 1109 394 393 96 90 162 159 50 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 76 29 

clinical_engagement 
diagnosis 
demography 
75 new agents 
113 
disease_progression 
H-positive risk:  696 676 92 1108 394 96 1130 385 158 55 160 50 
H-negative risk:  676 696 1130 1108 385 394 96 92 160 158 50 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
65 new agents 
114 
disease_progression 
H-positive risk:  700 671 91 1119 384 97 1124 385 160 57 161 51 
H-negative risk:  671 700 1124 1119 385 384 97 91 161 160 51 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
58 new agents 
115 
disease_progression 
H-positive risk:  704 664 93 1122 382 95 1127 383 159 57 161 53 
H-negative risk:  664 704 1127 1122 383 382 95 93 161 159 53 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 76 29 

clinical_engagement 
diagnosis 
demography 
66 new agents 
116 
disease_progression 
H-positive risk:  694 668 87 1117 387 96 1131 385 158 57 166 54 
H-negative risk:  668 694 1131 1117 385 387 96 87 166 158 54 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
117 
disease_progression 
H-positive risk:  701 672 86 1114 383 95 1131 386 156 56 168 52 
H-negative risk:  672 701 1131 1114 386 383 95 86 168 156 52 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 76 32 

clinical_engagement 
diagnosis 
demography 
83 new agents 
118 
disease_progression 
H-positive risk:  704 673 87 1113 381 95 1125 392 158 57 162 53 
H-negative risk:  673 704 1125 1113 392 381 95 87 162 158 53 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 74 31 

clinical_engagement 
diagnosis 
demography 
76 new agents 
119 
disease_progression 
H-positive risk:  710 677 84 1116 380 94 1116 393 157 56 164 53 
H-negative risk:  677 710 1116 1116 393 380 94 84 164 157 53 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 69 32 

clinical_engagement 
diagnosis 
demography 
54 new agents 
120 
disease_progression 
H-positive risk:  700 678 82 1118 381 93 1119 399 154 58 163 55 
H-negative risk:  678 700 1119 1118 399 381 93 82 163 154 55 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 69 31 

clinical_engagement 
diagnosis 
demography 
66 new agents 
121 
disease_progression 
H-positive risk:  656 651 78 1142 374 89 1169 404 156 58 167 56 
H-negative risk:  651 656 1169 1142 404 374 89 78 167 156 56 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
85 new agents 
122 
disease_progression 
H-positive risk:  649 645 76 1135 374 90 1178 411 154 61 171 56 
H-negative risk:  645 649 1178 1135 411 374 90 76 171 154 56 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 69 27 

clinical_engagement 
diagnosis 
demography 
96 new agents 
123 
disease_progression 
H-positive risk:  651 652 79 1143 367 92 1163 418 152 64 167 52 
H-negative risk:  652 651 1163 1143 418 367 92 79 167 152 52 64 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 65 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
124 
disease_progression 
H-positive risk:  651 640 79 1140 377 91 1164 425 152 63 167 51 
H-negative risk:  640 651 1164 1140 425 377 91 79 167 152 51 63 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 65 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
125 
disease_progression 
H-positive risk:  657 643 83 1139 371 89 1168 422 148 63 166 51 
H-negative risk:  643 657 1168 1139 422 371 89 83 166 148 51 63 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 65 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
126 
disease_progression 
H-positive risk:  655 648 84 1143 365 93 1172 413 147 61 168 51 
H-negative risk:  648 655 1172 1143 413 365 93 84 168 147 51 61 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
61 new agents 
127 
disease_progression 
H-positive risk:  657 650 86 1136 364 93 1176 411 147 60 166 54 
H-negative risk:  650 657 1176 1136 411 364 93 86 166 147 54 60 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
128 
disease_progression 
H-positive risk:  660 648 86 1126 372 94 1171 416 151 57 166 53 
H-negative risk:  648 660 1171 1126 416 372 94 86 166 151 53 57 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
89 new agents 
129 
disease_progression 
H-positive risk:  666 655 87 1124 373 95 1166 417 151 53 165 48 
H-negative risk:  655 666 1166 1124 417 373 95 87 165 151 48 53 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 69 23 

clinical_engagement 
diagnosis 
demography 
58 new agents 
130 
disease_progression 
H-positive risk:  659 656 86 1116 377 93 1180 413 153 54 165 48 
H-negative risk:  656 659 1180 1116 413 377 93 86 165 153 48 54 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
131 
disease_progression 
H-positive risk:  657 655 87 1124 375 91 1178 413 153 54 165 48 
H-negative risk:  655 657 1178 1124 413 375 91 87 165 153 48 54 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
132 
disease_progression 
H-positive risk:  665 661 88 1114 373 92 1170 419 153 54 161 50 
H-negative risk:  661 665 1170 1114 419 373 92 88 161 153 50 54 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 69 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
133 
disease_progression 
H-positive risk:  667 664 86 1115 378 90 1171 414 154 53 160 48 
H-negative risk:  664 667 1171 1115 414 378 90 86 160 154 48 53 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
134 
disease_progression 
H-positive risk:  671 667 87 1096 396 91 1167 410 150 56 163 46 
H-negative risk:  667 671 1167 1096 410 396 91 87 163 150 46 56 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
135 
disease_progression 
H-positive risk:  670 674 88 1097 401 91 1158 406 152 56 160 47 
H-negative risk:  674 670 1158 1097 406 401 91 88 160 152 47 56 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 70 20 

clinical_engagement 
diagnosis 
demography 
92 new agents 
136 
disease_progression 
H-positive risk:  678 677 88 1093 398 94 1157 400 154 55 159 47 
H-negative risk:  677 678 1157 1093 400 398 94 88 159 154 47 55 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 66 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
137 
disease_progression 
H-positive risk:  682 667 87 1105 396 93 1151 398 153 56 162 50 
H-negative risk:  667 682 1151 1105 398 396 93 87 162 153 50 56 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 66 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
138 
disease_progression 
H-positive risk:  682 672 88 1105 392 91 1157 394 155 56 159 49 
H-negative risk:  672 682 1157 1105 394 392 91 88 159 155 49 56 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 68 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
139 
disease_progression 
H-positive risk:  682 677 91 1103 393 92 1146 397 155 52 165 47 
H-negative risk:  677 682 1146 1103 397 393 92 91 165 155 47 52 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
59 new agents 
140 
disease_progression 
H-positive risk:  685 671 90 1111 387 96 1147 398 154 50 163 48 
H-negative risk:  671 685 1147 1111 398 387 96 90 163 154 48 50 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
141 
disease_progression 
H-positive risk:  679 666 90 1111 389 98 1154 395 156 49 164 49 
H-negative risk:  666 679 1154 1111 395 389 98 90 164 156 49 49 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
142 
disease_progression 
H-positive risk:  682 664 90 1107 388 99 1155 393 154 51 170 47 
H-negative risk:  664 682 1155 1107 393 388 99 90 170 154 47 51 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
143 
disease_progression 
H-positive risk:  679 655 85 1117 386 104 1155 397 152 52 172 46 
H-negative risk:  655 679 1155 1117 397 386 104 85 172 152 46 52 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 67 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
144 
disease_progression 
H-positive risk:  673 648 87 1123 392 104 1154 394 156 50 172 47 
H-negative risk:  648 673 1154 1123 394 392 104 87 172 156 47 50 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 66 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
145 
disease_progression 
H-positive risk:  674 641 86 1119 399 104 1152 402 153 50 171 49 
H-negative risk:  641 674 1152 1119 402 399 104 86 171 153 49 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
146 
disease_progression 
H-positive risk:  671 637 89 1116 404 105 1147 403 157 51 170 50 
H-negative risk:  637 671 1147 1116 403 404 105 89 170 157 50 51 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
147 
disease_progression 
H-positive risk:  664 637 88 1113 414 104 1154 400 156 53 169 48 
H-negative risk:  637 664 1154 1113 400 414 104 88 169 156 48 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
148 
disease_progression 
H-positive risk:  676 633 86 1116 412 106 1154 392 155 51 168 51 
H-negative risk:  633 676 1154 1116 392 412 106 86 168 155 51 51 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
149 
disease_progression 
H-positive risk:  674 633 88 1121 409 106 1150 392 155 50 170 52 
H-negative risk:  633 674 1150 1121 392 409 106 88 170 155 52 50 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
150 
disease_progression 
H-positive risk:  675 639 91 1122 405 104 1144 396 150 51 173 50 
H-negative risk:  639 675 1144 1122 396 405 104 91 173 150 50 51 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
151 
disease_progression 
H-positive risk:  679 631 90 1124 412 106 1135 399 150 52 170 52 
H-negative risk:  631 679 1135 1124 399 412 106 90 170 150 52 52 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
152 
disease_progression 
H-positive risk:  682 641 94 1122 406 103 1134 393 152 53 172 48 
H-negative risk:  641 682 1134 1122 393 406 103 94 172 152 48 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
57 new agents 
153 
disease_progression 
H-positive risk:  683 638 94 1124 410 101 1130 390 154 54 175 47 
H-negative risk:  638 683 1130 1124 390 410 101 94 175 154 47 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
154 
disease_progression 
H-positive risk:  686 641 94 1124 407 100 1125 394 154 53 173 49 
H-negative risk:  641 686 1125 1124 394 407 100 94 173 154 49 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
155 
disease_progression 
H-positive risk:  686 640 97 1134 398 101 1126 388 150 56 174 50 
H-negative risk:  640 686 1126 1134 388 398 101 97 174 150 50 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
156 
disease_progression 
H-positive risk:  687 639 96 1135 393 99 1136 385 151 56 174 49 
H-negative risk:  639 687 1136 1135 385 393 99 96 174 151 49 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
157 
disease_progression 
H-positive risk:  701 637 95 1127 394 100 1140 386 148 54 169 49 
H-negative risk:  637 701 1140 1127 386 394 100 95 169 148 49 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
158 
disease_progression 
H-positive risk:  703 638 92 1118 394 100 1135 401 148 55 171 45 
H-negative risk:  638 703 1135 1118 401 394 100 92 171 148 45 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
159 
disease_progression 
H-positive risk:  705 629 94 1125 388 100 1138 406 144 57 167 47 
H-negative risk:  629 705 1138 1125 406 388 100 94 167 144 47 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
57 new agents 
160 
disease_progression 
H-positive risk:  702 624 95 1132 394 101 1131 410 141 56 165 49 
H-negative risk:  624 702 1131 1132 410 394 101 95 165 141 49 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
161 
disease_progression 
H-positive risk:  698 619 96 1143 388 102 1133 409 140 55 165 52 
H-negative risk:  619 698 1133 1143 409 388 102 96 165 140 52 55 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 82 17 

clinical_engagement 
diagnosis 
demography 
85 new agents 
162 
disease_progression 
H-positive risk:  701 626 96 1139 381 100 1137 408 143 54 164 51 
H-negative risk:  626 701 1137 1139 408 381 100 96 164 143 51 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
163 
disease_progression 
H-positive risk:  700 630 97 1140 379 101 1135 407 140 56 161 54 
H-negative risk:  630 700 1135 1140 407 379 101 97 161 140 54 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
164 
disease_progression 
H-positive risk:  706 636 97 1135 384 96 1139 401 139 55 157 55 
H-negative risk:  636 706 1139 1135 401 384 96 97 157 139 55 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
165 
disease_progression 
H-positive risk:  717 642 99 1122 376 96 1140 396 145 53 156 58 
H-negative risk:  642 717 1140 1122 396 376 96 99 156 145 58 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
166 
disease_progression 
H-positive risk:  715 640 99 1115 379 98 1139 397 147 53 157 61 
H-negative risk:  640 715 1139 1115 397 379 98 99 157 147 61 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
167 
disease_progression 
H-positive risk:  719 635 98 1113 373 98 1153 397 144 54 155 61 
H-negative risk:  635 719 1153 1113 397 373 98 98 155 144 61 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
168 
disease_progression 
H-positive risk:  718 630 96 1112 375 96 1152 400 147 57 157 60 
H-negative risk:  630 718 1152 1112 400 375 96 96 157 147 60 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
169 
disease_progression 
H-positive risk:  716 633 97 1116 375 97 1157 389 150 57 153 60 
H-negative risk:  633 716 1157 1116 389 375 97 97 153 150 60 57 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
170 
disease_progression 
H-positive risk:  716 629 96 1109 379 97 1148 402 145 62 150 67 
H-negative risk:  629 716 1148 1109 402 379 97 96 150 145 67 62 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
171 
disease_progression 
H-positive risk:  717 635 94 1104 380 99 1145 399 146 61 150 70 
H-negative risk:  635 717 1145 1104 399 380 99 94 150 146 70 61 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
172 
disease_progression 
H-positive risk:  711 634 93 1107 389 99 1148 395 147 59 147 71 
H-negative risk:  634 711 1148 1107 395 389 99 93 147 147 71 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
173 
disease_progression 
H-positive risk:  709 631 92 1104 392 99 1156 393 148 60 148 68 
H-negative risk:  631 709 1156 1104 393 392 99 92 148 148 68 60 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
174 
disease_progression 
H-positive risk:  705 632 90 1109 394 102 1151 394 149 59 147 68 
H-negative risk:  632 705 1151 1109 394 394 102 90 147 149 68 59 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
175 
disease_progression 
H-positive risk:  705 633 90 1110 385 103 1155 392 153 57 147 70 
H-negative risk:  633 705 1155 1110 392 385 103 90 147 153 70 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
61 new agents 
176 
disease_progression 
H-positive risk:  698 630 90 1105 383 103 1165 396 152 58 150 70 
H-negative risk:  630 698 1165 1105 396 383 103 90 150 152 70 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
177 
disease_progression 
H-positive risk:  703 634 91 1102 384 98 1156 395 154 62 152 69 
H-negative risk:  634 703 1156 1102 395 384 98 91 152 154 69 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
99 new agents 
178 
disease_progression 
H-positive risk:  697 635 91 1104 387 96 1149 402 157 61 154 67 
H-negative risk:  635 697 1149 1104 402 387 96 91 154 157 67 61 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
62 new agents 
179 
disease_progression 
H-positive risk:  691 642 94 1104 386 95 1149 405 157 60 152 65 
H-negative risk:  642 691 1149 1104 405 386 95 94 152 157 65 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
180 
disease_progression 
H-positive risk:  690 649 95 1103 387 96 1149 406 155 61 151 58 
H-negative risk:  649 690 1149 1103 406 387 96 95 151 155 58 61 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
181 
disease_progression 
H-positive risk:  699 644 96 1115 386 95 1149 395 152 61 149 59 
H-negative risk:  644 699 1149 1115 395 386 95 96 149 152 59 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
87 new agents 
182 
disease_progression 
H-positive risk:  693 642 94 1114 394 92 1146 402 157 60 145 61 
H-negative risk:  642 693 1146 1114 402 394 92 94 145 157 61 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
183 
disease_progression 
H-positive risk:  695 636 94 1116 392 91 1146 406 157 60 147 60 
H-negative risk:  636 695 1146 1116 406 392 91 94 147 157 60 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
184 
disease_progression 
H-positive risk:  692 627 93 1130 382 92 1151 410 152 63 148 60 
H-negative risk:  627 692 1151 1130 410 382 92 93 148 152 60 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
185 
disease_progression 
H-positive risk:  696 626 91 1129 380 88 1158 407 153 64 149 59 
H-negative risk:  626 696 1158 1129 407 380 88 91 149 153 59 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
186 
disease_progression 
H-positive risk:  695 627 93 1121 379 90 1158 408 155 66 151 57 
H-negative risk:  627 695 1158 1121 408 379 90 93 151 155 57 66 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
187 
disease_progression 
H-positive risk:  695 626 91 1131 379 91 1149 412 154 65 154 53 
H-negative risk:  626 695 1149 1131 412 379 91 91 154 154 53 65 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
188 
disease_progression 
H-positive risk:  690 621 92 1141 378 91 1155 412 151 63 151 55 
H-negative risk:  621 690 1155 1141 412 378 91 92 151 151 55 63 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
189 
disease_progression 
H-positive risk:  693 626 95 1141 373 93 1153 406 151 65 152 52 
H-negative risk:  626 693 1153 1141 406 373 93 95 152 151 52 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
190 
disease_progression 
H-positive risk:  694 630 95 1142 375 93 1153 399 149 64 154 52 
H-negative risk:  630 694 1153 1142 399 375 93 95 154 149 52 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
191 
disease_progression 
H-positive risk:  697 628 94 1140 378 95 1148 403 147 65 153 52 
H-negative risk:  628 697 1148 1140 403 378 95 94 153 147 52 65 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
192 
disease_progression 
H-positive risk:  701 624 94 1133 389 97 1152 392 149 64 150 55 
H-negative risk:  624 701 1152 1133 392 389 97 94 150 149 55 64 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
96 new agents 
193 
disease_progression 
H-positive risk:  696 618 93 1133 389 95 1162 390 153 65 151 55 
H-negative risk:  618 696 1162 1133 390 389 95 93 151 153 55 65 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
194 
disease_progression 
H-positive risk:  694 608 92 1133 390 95 1158 405 151 66 151 57 
H-negative risk:  608 694 1158 1133 405 390 95 92 151 151 57 66 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
195 
disease_progression 
H-positive risk:  701 610 91 1125 388 97 1162 404 151 64 151 56 
H-negative risk:  610 701 1162 1125 404 388 97 91 151 151 56 64 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
91 new agents 
196 
disease_progression 
H-positive risk:  704 611 93 1124 386 98 1157 405 155 62 148 57 
H-negative risk:  611 704 1157 1124 405 386 98 93 148 155 57 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
197 
disease_progression 
H-positive risk:  705 618 92 1114 390 99 1160 404 156 61 144 57 
H-negative risk:  618 705 1160 1114 404 390 99 92 144 156 57 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
198 
disease_progression 
H-positive risk:  697 615 93 1118 393 93 1155 408 162 62 146 58 
H-negative risk:  615 697 1155 1118 408 393 93 93 146 162 58 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
63 new agents 
199 
disease_progression 
H-positive risk:  697 605 95 1123 391 92 1149 415 163 61 148 61 
H-negative risk:  605 697 1149 1123 415 391 92 95 148 163 61 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
200 
disease_progression 
H-positive risk:  707 608 94 1114 395 94 1146 416 162 58 147 59 
H-negative risk:  608 707 1146 1114 416 395 94 94 147 162 59 58 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
87 new agents 
201 
disease_progression 
H-positive risk:  712 610 93 1116 389 95 1152 406 159 58 150 60 
H-negative risk:  610 712 1152 1116 406 389 95 93 150 159 60 58 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
202 
disease_progression 
H-positive risk:  708 612 94 1115 387 98 1157 400 157 61 151 60 
H-negative risk:  612 708 1157 1115 400 387 98 94 151 157 60 61 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
203 
disease_progression 
H-positive risk:  711 614 94 1105 392 100 1164 389 159 62 152 58 
H-negative risk:  614 711 1164 1105 389 392 100 94 152 159 58 62 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
83 new agents 
204 
disease_progression 
H-positive risk:  712 611 91 1104 396 96 1163 386 166 62 153 60 
H-negative risk:  611 712 1163 1104 386 396 96 91 153 166 60 62 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
205 
disease_progression 
H-positive risk:  711 614 93 1112 389 98 1159 381 166 61 156 60 
H-negative risk:  614 711 1159 1112 381 389 98 93 156 166 60 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
206 
disease_progression 
H-positive risk:  724 612 91 1106 396 98 1143 389 165 63 155 58 
H-negative risk:  612 724 1143 1106 389 396 98 91 155 165 58 63 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
207 
disease_progression 
H-positive risk:  718 602 90 1110 394 96 1144 399 168 63 155 61 
H-negative risk:  602 718 1144 1110 399 394 96 90 155 168 61 63 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
208 
disease_progression 
H-positive risk:  714 599 92 1110 397 98 1143 397 172 62 154 62 
H-negative risk:  599 714 1143 1110 397 397 98 92 154 172 62 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
55 new agents 
209 
disease_progression 
H-positive risk:  713 598 90 1111 391 97 1144 405 172 62 151 66 
H-negative risk:  598 713 1144 1111 405 391 97 90 151 172 66 62 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
210 
disease_progression 
H-positive risk:  718 587 93 1121 389 96 1146 404 172 60 149 65 
H-negative risk:  587 718 1146 1121 404 389 96 93 149 172 65 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
211 
disease_progression 
H-positive risk:  729 582 96 1120 398 96 1143 399 169 61 145 62 
H-negative risk:  582 729 1143 1120 399 398 96 96 145 169 62 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
212 
disease_progression 
H-positive risk:  730 583 97 1123 388 95 1143 398 173 60 146 64 
H-negative risk:  583 730 1143 1123 398 388 95 97 146 173 64 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
213 
disease_progression 
H-positive risk:  720 581 97 1128 395 99 1142 395 170 60 149 64 
H-negative risk:  581 720 1142 1128 395 395 99 97 149 170 64 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
214 
disease_progression 
H-positive risk:  716 577 96 1119 410 97 1140 395 172 57 156 65 
H-negative risk:  577 716 1140 1119 395 410 97 96 156 172 65 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
99 new agents 
215 
disease_progression 
H-positive risk:  712 591 98 1115 400 97 1144 395 168 58 158 64 
H-negative risk:  591 712 1144 1115 395 400 97 98 158 168 64 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
216 
disease_progression 
H-positive risk:  713 599 98 1105 396 101 1150 393 164 59 157 65 
H-negative risk:  599 713 1150 1105 393 396 101 98 157 164 65 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
217 
disease_progression 
H-positive risk:  714 603 98 1093 408 100 1141 406 155 61 154 67 
H-negative risk:  603 714 1141 1093 406 408 100 98 154 155 67 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
218 
disease_progression 
H-positive risk:  712 601 99 1101 401 101 1138 406 154 66 155 66 
H-negative risk:  601 712 1138 1101 406 401 101 99 155 154 66 66 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
219 
disease_progression 
H-positive risk:  712 606 96 1105 402 102 1128 413 152 63 155 66 
H-negative risk:  606 712 1128 1105 413 402 102 96 155 152 66 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
220 
disease_progression 
H-positive risk:  714 610 98 1097 400 103 1125 413 151 66 160 63 
H-negative risk:  610 714 1125 1097 413 400 103 98 160 151 63 66 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
221 
disease_progression 
H-positive risk:  726 613 97 1099 399 102 1119 406 150 67 159 63 
H-negative risk:  613 726 1119 1099 406 399 102 97 159 150 63 67 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
222 
disease_progression 
H-positive risk:  718 606 98 1107 396 104 1121 410 152 66 157 65 
H-negative risk:  606 718 1121 1107 410 396 104 98 157 152 65 66 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
223 
disease_progression 
H-positive risk:  712 606 97 1107 402 102 1116 413 154 65 164 62 
H-negative risk:  606 712 1116 1107 413 402 102 97 164 154 62 65 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
224 
disease_progression 
H-positive risk:  714 602 97 1108 403 103 1122 410 157 62 162 60 
H-negative risk:  602 714 1122 1108 410 403 103 97 162 157 60 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
225 
disease_progression 
H-positive risk:  709 608 96 1104 406 100 1117 418 159 61 163 59 
H-negative risk:  608 709 1117 1104 418 406 100 96 163 159 59 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
226 
disease_progression 
H-positive risk:  709 609 97 1106 407 99 1112 414 160 61 165 61 
H-negative risk:  609 709 1112 1106 414 407 99 97 165 160 61 61 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
227 
disease_progression 
H-positive risk:  715 606 99 1110 409 96 1097 423 161 60 160 64 
H-negative risk:  606 715 1097 1110 423 409 96 99 160 161 64 60 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
228 
disease_progression 
H-positive risk:  717 614 98 1110 410 94 1093 422 163 57 159 63 
H-negative risk:  614 717 1093 1110 422 410 94 98 159 163 63 57 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 90 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
229 
disease_progression 
H-positive risk:  713 615 97 1098 422 97 1094 423 163 57 157 64 
H-negative risk:  615 713 1094 1098 423 422 97 97 157 163 64 57 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
90 new agents 
230 
disease_progression 
H-positive risk:  720 628 98 1087 422 96 1089 429 159 51 157 64 
H-negative risk:  628 720 1089 1087 429 422 96 98 157 159 64 51 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
231 
disease_progression 
H-positive risk:  722 625 99 1085 430 96 1090 422 159 54 156 62 
H-negative risk:  625 722 1090 1085 422 430 96 99 156 159 62 54 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
232 
disease_progression 
H-positive risk:  727 623 100 1078 432 94 1094 418 162 55 156 61 
H-negative risk:  623 727 1094 1078 418 432 94 100 156 162 61 55 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 94 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
233 
disease_progression 
H-positive risk:  725 614 105 1083 433 90 1091 420 167 54 156 62 
H-negative risk:  614 725 1091 1083 420 433 90 105 156 167 62 54 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 94 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
234 
disease_progression 
H-positive risk:  725 618 102 1072 433 94 1097 416 167 54 159 63 
H-negative risk:  618 725 1097 1072 416 433 94 102 159 167 63 54 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 94 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
235 
disease_progression 
H-positive risk:  713 626 102 1063 430 94 1102 426 166 57 157 64 
H-negative risk:  626 713 1102 1063 426 430 94 102 157 166 64 57 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
236 
disease_progression 
H-positive risk:  711 625 102 1065 426 97 1109 423 166 57 156 63 
H-negative risk:  625 711 1109 1065 423 426 97 102 156 166 63 57 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
237 
disease_progression 
H-positive risk:  715 630 103 1059 425 94 1112 418 169 54 156 65 
H-negative risk:  630 715 1112 1059 418 425 94 103 156 169 65 54 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
238 
disease_progression 
H-positive risk:  713 638 101 1057 424 92 1114 411 170 57 159 64 
H-negative risk:  638 713 1114 1057 411 424 92 101 159 170 64 57 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
239 
disease_progression 
H-positive risk:  713 636 101 1066 424 90 1107 416 168 57 160 62 
H-negative risk:  636 713 1107 1066 416 424 90 101 160 168 62 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
240 
disease_progression 
H-positive risk:  716 635 98 1066 427 89 1103 421 169 56 158 62 
H-negative risk:  635 716 1103 1066 421 427 89 98 158 169 62 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
241 
disease_progression 
H-positive risk:  717 638 98 1060 436 89 1089 422 171 55 162 63 
H-negative risk:  638 717 1089 1060 422 436 89 98 162 171 63 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
242 
disease_progression 
H-positive risk:  716 633 100 1072 433 91 1086 414 171 56 164 64 
H-negative risk:  633 716 1086 1072 414 433 91 100 164 171 64 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
243 
disease_progression 
H-positive risk:  714 631 99 1072 437 93 1084 415 168 58 165 64 
H-negative risk:  631 714 1084 1072 415 437 93 99 165 168 64 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
244 
disease_progression 
H-positive risk:  713 632 100 1071 436 95 1075 422 168 59 165 64 
H-negative risk:  632 713 1075 1071 422 436 95 100 165 168 64 59 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
245 
disease_progression 
H-positive risk:  712 635 103 1072 428 95 1075 425 167 56 166 66 
H-negative risk:  635 712 1075 1072 425 428 95 103 166 167 66 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
246 
disease_progression 
H-positive risk:  728 635 101 1063 423 94 1072 430 165 56 167 66 
H-negative risk:  635 728 1072 1063 430 423 94 101 167 165 66 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
247 
disease_progression 
H-positive risk:  717 641 99 1063 428 97 1068 433 166 57 166 65 
H-negative risk:  641 717 1068 1063 433 428 97 99 166 166 65 57 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
248 
disease_progression 
H-positive risk:  715 642 98 1061 423 97 1077 435 167 55 162 68 
H-negative risk:  642 715 1077 1061 435 423 97 98 162 167 68 55 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
249 
disease_progression 
H-positive risk:  711 637 99 1068 422 98 1082 435 165 53 165 65 
H-negative risk:  637 711 1082 1068 435 422 98 99 165 165 65 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
250 
disease_progression 
H-positive risk:  711 644 101 1054 426 101 1082 435 163 52 163 68 
H-negative risk:  644 711 1082 1054 435 426 101 101 163 163 68 52 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
251 
disease_progression 
H-positive risk:  716 641 99 1059 425 100 1084 435 166 48 163 64 
H-negative risk:  641 716 1084 1059 435 425 100 99 163 166 64 48 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
252 
disease_progression 
H-positive risk:  714 636 99 1069 425 100 1077 430 170 49 165 66 
H-negative risk:  636 714 1077 1069 430 425 100 99 165 170 66 49 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
253 
disease_progression 
H-positive risk:  715 636 97 1071 420 99 1078 427 169 51 170 67 
H-negative risk:  636 715 1078 1071 427 420 99 97 170 169 67 51 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 93 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
254 
disease_progression 
H-positive risk:  717 634 97 1070 421 100 1084 428 168 51 164 66 
H-negative risk:  634 717 1084 1070 428 421 100 97 164 168 66 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
255 
disease_progression 
H-positive risk:  719 638 95 1062 426 100 1084 429 170 50 163 64 
H-negative risk:  638 719 1084 1062 429 426 100 95 163 170 64 50 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 90 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
256 
disease_progression 
H-positive risk:  719 642 97 1062 427 98 1087 426 171 47 159 65 
H-negative risk:  642 719 1087 1062 426 427 98 97 159 171 65 47 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 90 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
257 
disease_progression 
H-positive risk:  717 644 98 1062 432 96 1088 422 169 46 159 67 
H-negative risk:  644 717 1088 1062 422 432 96 98 159 169 67 46 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
83 new agents 
258 
disease_progression 
H-positive risk:  725 642 98 1060 428 93 1089 424 170 44 157 70 
H-negative risk:  642 725 1089 1060 424 428 93 98 157 170 70 44 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 94 18 

clinical_engagement 
diagnosis 
demography 
101 new agents 
259 
disease_progression 
H-positive risk:  727 644 99 1062 425 92 1093 419 169 45 157 68 
H-negative risk:  644 727 1093 1062 419 425 92 99 157 169 68 45 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
260 
disease_progression 
H-positive risk:  729 647 95 1053 432 86 1098 415 172 45 162 66 
H-negative risk:  647 729 1098 1053 415 432 86 95 162 172 66 45 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
261 
disease_progression 
H-positive risk:  727 640 94 1067 434 87 1083 421 171 45 165 66 
H-negative risk:  640 727 1083 1067 421 434 87 94 165 171 66 45 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
85 new agents 
262 
disease_progression 
H-positive risk:  723 642 96 1065 436 87 1082 422 172 43 162 70 
H-negative risk:  642 723 1082 1065 422 436 87 96 162 172 70 43 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 95 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
263 
disease_progression 
H-positive risk:  721 648 95 1065 434 88 1081 424 168 45 159 72 
H-negative risk:  648 721 1081 1065 424 434 88 95 159 168 72 45 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 95 20 

clinical_engagement 
diagnosis 
demography 
59 new agents 
264 
disease_progression 
H-positive risk:  716 657 95 1065 429 86 1087 420 169 47 156 73 
H-negative risk:  657 716 1087 1065 420 429 86 95 156 169 73 47 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 96 22 

clinical_engagement 
diagnosis 
demography 
94 new agents 
265 
disease_progression 
H-positive risk:  712 661 96 1058 435 88 1088 417 166 51 156 72 
H-negative risk:  661 712 1088 1058 417 435 88 96 156 166 72 51 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 98 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
266 
disease_progression 
H-positive risk:  716 660 96 1058 434 86 1084 422 166 51 154 73 
H-negative risk:  660 716 1084 1058 422 434 86 96 154 166 73 51 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 96 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
267 
disease_progression 
H-positive risk:  721 662 95 1057 431 87 1077 427 163 53 155 72 
H-negative risk:  662 721 1077 1057 427 431 87 95 155 163 72 53 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 98 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
268 
disease_progression 
H-positive risk:  724 662 95 1065 431 85 1064 428 166 52 154 74 
H-negative risk:  662 724 1064 1065 428 431 85 95 154 166 74 52 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 97 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
269 
disease_progression 
H-positive risk:  722 668 92 1067 435 84 1061 421 166 55 154 75 
H-negative risk:  668 722 1061 1067 421 435 84 92 154 166 75 55 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 101 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
270 
disease_progression 
H-positive risk:  718 663 94 1075 434 87 1067 415 164 55 154 74 
H-negative risk:  663 718 1067 1075 415 434 87 94 154 164 74 55 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 103 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
271 
disease_progression 
H-positive risk:  714 658 96 1073 443 86 1063 411 166 57 157 76 
H-negative risk:  658 714 1063 1073 411 443 86 96 157 166 76 57 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 102 22 

clinical_engagement 
diagnosis 
demography 
63 new agents 
272 
disease_progression 
H-positive risk:  716 659 99 1073 446 86 1062 409 164 55 155 76 
H-negative risk:  659 716 1062 1073 409 446 86 99 155 164 76 55 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 102 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
273 
disease_progression 
H-positive risk:  727 657 97 1074 438 87 1069 398 166 56 153 78 
H-negative risk:  657 727 1069 1074 398 438 87 97 153 166 78 56 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 103 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
274 
disease_progression 
H-positive risk:  718 656 95 1081 433 88 1074 401 161 55 158 80 
H-negative risk:  656 718 1074 1081 401 433 88 95 158 161 80 55 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 100 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
275 
disease_progression 
H-positive risk:  718 661 94 1086 433 89 1074 399 161 53 154 78 
H-negative risk:  661 718 1074 1086 399 433 89 94 154 161 78 53 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 98 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
276 
disease_progression 
H-positive risk:  718 666 98 1082 428 87 1074 402 161 53 154 77 
H-negative risk:  666 718 1074 1082 402 428 87 98 154 161 77 53 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 98 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
277 
disease_progression 
H-positive risk:  714 657 100 1088 423 88 1070 411 163 53 153 80 
H-negative risk:  657 714 1070 1088 411 423 88 100 153 163 80 53 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 99 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
278 
disease_progression 
H-positive risk:  710 665 99 1080 427 87 1073 415 162 51 151 80 
H-negative risk:  665 710 1073 1080 415 427 87 99 151 162 80 51 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
279 
disease_progression 
H-positive risk:  713 668 99 1076 427 86 1075 409 164 52 154 77 
H-negative risk:  668 713 1075 1076 409 427 86 99 154 164 77 52 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 97 24 

clinical_engagement 
diagnosis 
demography 
57 new agents 
280 
disease_progression 
H-positive risk:  710 664 98 1074 434 86 1077 411 164 51 154 77 
H-negative risk:  664 710 1077 1074 411 434 86 98 154 164 77 51 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 97 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
281 
disease_progression 
H-positive risk:  716 665 99 1070 434 89 1083 401 163 51 153 76 
H-negative risk:  665 716 1083 1070 401 434 89 99 153 163 76 51 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 99 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
282 
disease_progression 
H-positive risk:  709 672 102 1056 440 88 1086 406 159 50 154 78 
H-negative risk:  672 709 1086 1056 406 440 88 102 154 159 78 50 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 100 26 

clinical_engagement 
diagnosis 
demography 
62 new agents 
283 
disease_progression 
H-positive risk:  708 671 101 1054 448 86 1083 406 158 49 155 81 
H-negative risk:  671 708 1083 1054 406 448 86 101 155 158 81 49 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 99 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
284 
disease_progression 
H-positive risk:  702 676 101 1043 450 90 1098 398 156 49 153 84 
H-negative risk:  676 702 1098 1043 398 450 90 101 153 156 84 49 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 97 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
285 
disease_progression 
H-positive risk:  699 666 102 1051 454 88 1108 394 154 50 152 82 
H-negative risk:  666 699 1108 1051 394 454 88 102 152 154 82 50 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 101 28 

clinical_engagement 
diagnosis 
demography 
72 new agents 
286 
disease_progression 
H-positive risk:  703 657 102 1062 449 89 1105 398 155 49 152 79 
H-negative risk:  657 703 1105 1062 398 449 89 102 152 155 79 49 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 99 28 

clinical_engagement 
diagnosis 
demography 
68 new agents 
287 
disease_progression 
H-positive risk:  694 654 101 1065 450 88 1107 396 160 50 156 79 
H-negative risk:  654 694 1107 1065 396 450 88 101 156 160 79 50 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 95 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
288 
disease_progression 
H-positive risk:  689 656 99 1064 445 88 1121 394 163 49 153 79 
H-negative risk:  656 689 1121 1064 394 445 88 99 153 163 79 49 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 93 28 

clinical_engagement 
diagnosis 
demography 
71 new agents 
289 
disease_progression 
H-positive risk:  689 649 103 1068 455 86 1121 391 161 48 154 75 
H-negative risk:  649 689 1121 1068 391 455 86 103 154 161 75 48 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 92 28 

clinical_engagement 
diagnosis 
demography 
97 new agents 
290 
disease_progression 
H-positive risk:  676 646 106 1068 453 89 1137 387 164 49 153 72 
H-negative risk:  646 676 1137 1068 387 453 89 106 153 164 72 49 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 94 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
291 
disease_progression 
H-positive risk:  679 649 107 1065 451 86 1124 399 165 47 155 73 
H-negative risk:  649 679 1124 1065 399 451 86 107 155 165 73 47 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 90 34 

clinical_engagement 
diagnosis 
demography 
65 new agents 
292 
disease_progression 
H-positive risk:  672 652 105 1072 446 87 1126 404 164 48 154 70 
H-negative risk:  652 672 1126 1072 404 446 87 105 154 164 70 48 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 87 34 

clinical_engagement 
diagnosis 
demography 
79 new agents 
293 
disease_progression 
H-positive risk:  673 653 106 1075 439 87 1121 408 164 53 154 67 
H-negative risk:  653 673 1121 1075 408 439 87 106 154 164 67 53 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 85 32 

clinical_engagement 
diagnosis 
demography 
62 new agents 
294 
disease_progression 
H-positive risk:  678 652 106 1081 433 87 1109 418 164 54 153 65 
H-negative risk:  652 678 1109 1081 418 433 87 106 153 164 65 54 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 88 33 

clinical_engagement 
diagnosis 
demography 
76 new agents 
295 
disease_progression 
H-positive risk:  682 647 106 1084 434 87 1110 416 164 53 153 64 
H-negative risk:  647 682 1110 1084 416 434 87 106 153 164 64 53 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 89 33 

clinical_engagement 
diagnosis 
demography 
77 new agents 
296 
disease_progression 
H-positive risk:  681 640 106 1080 438 85 1111 416 171 54 153 65 
H-negative risk:  640 681 1111 1080 416 438 85 106 153 171 65 54 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 87 33 

clinical_engagement 
diagnosis 
demography 
87 new agents 
297 
disease_progression 
H-positive risk:  679 640 109 1081 435 83 1111 413 174 56 155 64 
H-negative risk:  640 679 1111 1081 413 435 83 109 155 174 64 56 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 83 32 

clinical_engagement 
diagnosis 
demography 
68 new agents 
298 
disease_progression 
H-positive risk:  680 645 107 1074 437 86 1104 422 173 54 155 63 
H-negative risk:  645 680 1104 1074 422 437 86 107 155 173 63 54 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 83 32 

clinical_engagement 
diagnosis 
demography 
73 new agents 
299 
disease_progression 
H-positive risk:  681 644 104 1075 434 89 1112 420 170 56 153 62 
H-negative risk:  644 681 1112 1075 420 434 89 104 153 170 62 56 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 84 32 

clinical_engagement 
diagnosis 
demography 
73 new agents 
300 
disease_progression 
H-positive risk:  684 643 105 1084 435 88 1098 424 170 54 150 65 
H-negative risk:  643 684 1098 1084 424 435 88 105 150 170 65 54 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
301 
disease_progression 
H-positive risk:  693 649 106 1079 437 88 1093 420 169 52 147 67 
H-negative risk:  649 693 1093 1079 420 437 88 106 147 169 67 52 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 84 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
302 
disease_progression 
H-positive risk:  690 653 107 1078 438 89 1101 408 171 51 148 66 
H-negative risk:  653 690 1101 1078 408 438 89 107 148 171 66 51 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 84 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
303 
disease_progression 
H-positive risk:  696 659 114 1070 439 91 1099 397 169 56 148 62 
H-negative risk:  659 696 1099 1070 397 439 91 114 148 169 62 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 82 29 

clinical_engagement 
diagnosis 
demography 
88 new agents 
304 
disease_progression 
H-positive risk:  698 670 112 1066 440 90 1099 390 171 55 146 63 
H-negative risk:  670 698 1099 1066 390 440 90 112 146 171 63 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 80 29 

clinical_engagement 
diagnosis 
demography 
83 new agents 
305 
disease_progression 
H-positive risk:  691 678 112 1055 440 97 1099 388 175 54 146 65 
H-negative risk:  678 691 1099 1055 388 440 97 112 146 175 65 54 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 81 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
306 
disease_progression 
H-positive risk:  695 681 113 1048 440 97 1101 392 175 52 142 64 
H-negative risk:  681 695 1101 1048 392 440 97 113 142 175 64 52 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 81 30 

clinical_engagement 
diagnosis 
demography 
69 new agents 
307 
disease_progression 
H-positive risk:  694 685 114 1045 430 96 1107 392 177 51 142 67 
H-negative risk:  685 694 1107 1045 392 430 96 114 142 177 67 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
77 new agents 
308 
disease_progression 
H-positive risk:  695 680 117 1054 433 93 1104 391 175 50 138 70 
H-negative risk:  680 695 1104 1054 391 433 93 117 138 175 70 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
83 new agents 
309 
disease_progression 
H-positive risk:  703 688 118 1050 431 93 1094 387 176 52 138 70 
H-negative risk:  688 703 1094 1050 387 431 93 118 138 176 70 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 81 29 

clinical_engagement 
diagnosis 
demography 
88 new agents 
310 
disease_progression 
H-positive risk:  704 681 120 1060 427 93 1103 380 177 52 135 68 
H-negative risk:  681 704 1103 1060 380 427 93 120 135 177 68 52 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
311 
disease_progression 
H-positive risk:  708 685 118 1056 426 91 1097 382 176 52 139 70 
H-negative risk:  685 708 1097 1056 382 426 91 118 139 176 70 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
59 new agents 
312 
disease_progression 
H-positive risk:  705 690 117 1051 430 89 1102 381 174 57 137 67 
H-negative risk:  690 705 1102 1051 381 430 89 117 137 174 67 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
313 
disease_progression 
H-positive risk:  709 692 117 1051 425 91 1100 384 173 52 138 68 
H-negative risk:  692 709 1100 1051 384 425 91 117 138 173 68 52 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 78 30 

clinical_engagement 
diagnosis 
demography 
87 new agents 
314 
disease_progression 
H-positive risk:  719 686 118 1049 421 92 1100 384 168 54 140 69 
H-negative risk:  686 719 1100 1049 384 421 92 118 140 168 69 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
90 new agents 
315 
disease_progression 
H-positive risk:  712 692 118 1050 416 90 1108 378 165 57 146 68 
H-negative risk:  692 712 1108 1050 378 416 90 118 146 165 68 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 74 31 

clinical_engagement 
diagnosis 
demography 
84 new agents 
316 
disease_progression 
H-positive risk:  712 690 115 1047 415 90 1116 381 162 55 148 69 
H-negative risk:  690 712 1116 1047 381 415 90 115 148 162 69 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 71 32 

clinical_engagement 
diagnosis 
demography 
73 new agents 
317 
disease_progression 
H-positive risk:  712 685 110 1053 413 89 1123 378 162 57 151 67 
H-negative risk:  685 712 1123 1053 378 413 89 110 151 162 67 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
69 new agents 
318 
disease_progression 
H-positive risk:  712 690 108 1046 409 89 1123 386 162 56 153 66 
H-negative risk:  690 712 1123 1046 386 409 89 108 153 162 66 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 75 31 

clinical_engagement 
diagnosis 
demography 
68 new agents 
319 
disease_progression 
H-positive risk:  714 695 106 1039 407 91 1121 391 162 54 155 65 
H-negative risk:  695 714 1121 1039 391 407 91 106 155 162 65 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 74 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
320 
disease_progression 
H-positive risk:  705 691 107 1041 403 93 1126 399 159 56 154 66 
H-negative risk:  691 705 1126 1041 399 403 93 107 154 159 66 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 73 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
321 
disease_progression 
H-positive risk:  705 690 104 1045 397 92 1138 392 157 57 158 65 
H-negative risk:  690 705 1138 1045 392 397 92 104 158 157 65 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
93 new agents 
322 
disease_progression 
H-positive risk:  715 696 105 1039 395 95 1137 388 156 55 157 62 
H-negative risk:  696 715 1137 1039 388 395 95 105 157 156 62 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 74 32 

clinical_engagement 
diagnosis 
demography 
72 new agents 
323 
disease_progression 
H-positive risk:  715 687 101 1036 402 97 1131 397 157 54 157 66 
H-negative risk:  687 715 1131 1036 397 402 97 101 157 157 66 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 75 32 

clinical_engagement 
diagnosis 
demography 
85 new agents 
324 
disease_progression 
H-positive risk:  709 686 102 1037 398 98 1124 406 160 53 162 65 
H-negative risk:  686 709 1124 1037 406 398 98 102 162 160 65 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 76 30 

clinical_engagement 
diagnosis 
demography 
86 new agents 
325 
disease_progression 
H-positive risk:  706 687 101 1040 395 100 1129 407 155 53 160 67 
H-negative risk:  687 706 1129 1040 407 395 100 101 160 155 67 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 76 31 

clinical_engagement 
diagnosis 
demography 
68 new agents 
326 
disease_progression 
H-positive risk:  710 685 102 1048 392 99 1126 400 159 55 157 67 
H-negative risk:  685 710 1126 1048 400 392 99 102 157 159 67 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 78 31 

clinical_engagement 
diagnosis 
demography 
79 new agents 
327 
disease_progression 
H-positive risk:  707 677 100 1053 392 100 1130 402 161 54 160 64 
H-negative risk:  677 707 1130 1053 402 392 100 100 160 161 64 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
69 new agents 
328 
disease_progression 
H-positive risk:  701 675 100 1060 389 101 1131 399 163 53 159 69 
H-negative risk:  675 701 1131 1060 399 389 101 100 159 163 69 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 81 31 

clinical_engagement 
diagnosis 
demography 
71 new agents 
329 
disease_progression 
H-positive risk:  699 680 100 1065 381 104 1114 411 161 52 163 70 
H-negative risk:  680 699 1114 1065 411 381 104 100 163 161 70 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
72 new agents 
330 
disease_progression 
H-positive risk:  696 675 98 1068 389 101 1127 408 160 48 160 70 
H-negative risk:  675 696 1127 1068 408 389 101 98 160 160 70 48 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 81 31 

clinical_engagement 
diagnosis 
demography 
85 new agents 
331 
disease_progression 
H-positive risk:  700 677 100 1064 385 103 1138 396 160 48 161 68 
H-negative risk:  677 700 1138 1064 396 385 103 100 161 160 68 48 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 82 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
332 
disease_progression 
H-positive risk:  705 671 99 1066 380 106 1141 397 157 50 159 69 
H-negative risk:  671 705 1141 1066 397 380 106 99 159 157 69 50 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 82 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
333 
disease_progression 
H-positive risk:  708 675 99 1060 382 104 1134 399 159 47 165 68 
H-negative risk:  675 708 1134 1060 399 382 104 99 165 159 68 47 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 84 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
334 
disease_progression 
H-positive risk:  706 680 99 1051 380 103 1140 400 159 46 167 69 
H-negative risk:  680 706 1140 1051 400 380 103 99 167 159 69 46 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 82 32 

clinical_engagement 
diagnosis 
demography 
80 new agents 
335 
disease_progression 
H-positive risk:  700 685 97 1043 381 100 1151 402 162 45 167 67 
H-negative risk:  685 700 1151 1043 402 381 100 97 167 162 67 45 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 83 31 

clinical_engagement 
diagnosis 
demography 
79 new agents 
336 
disease_progression 
H-positive risk:  694 679 98 1047 385 100 1151 402 163 47 169 65 
H-negative risk:  679 694 1151 1047 402 385 100 98 169 163 65 47 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 82 31 

clinical_engagement 
diagnosis 
demography 
59 new agents 
337 
disease_progression 
H-positive risk:  687 678 97 1046 386 100 1151 410 162 48 171 64 
H-negative risk:  678 687 1151 1046 410 386 100 97 171 162 64 48 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 84 30 

clinical_engagement 
diagnosis 
demography 
90 new agents 
338 
disease_progression 
H-positive risk:  682 687 95 1037 389 97 1155 405 165 51 170 67 
H-negative risk:  687 682 1155 1037 405 389 97 95 170 165 67 51 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 82 31 

clinical_engagement 
diagnosis 
demography 
84 new agents 
339 
disease_progression 
H-positive risk:  674 698 95 1037 389 98 1148 404 166 51 171 69 
H-negative risk:  698 674 1148 1037 404 389 98 95 171 166 69 51 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 84 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
340 
disease_progression 
H-positive risk:  661 702 97 1033 400 98 1151 406 169 46 168 69 
H-negative risk:  702 661 1151 1033 406 400 98 97 168 169 69 46 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 79 32 

clinical_engagement 
diagnosis 
demography 
77 new agents 
341 
disease_progression 
H-positive risk:  660 702 96 1031 400 99 1153 409 166 47 169 68 
H-negative risk:  702 660 1153 1031 409 400 99 96 169 166 68 47 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 82 33 

clinical_engagement 
diagnosis 
demography 
82 new agents 
342 
disease_progression 
H-positive risk:  666 694 95 1045 389 100 1148 411 162 51 170 69 
H-negative risk:  694 666 1148 1045 411 389 100 95 170 162 69 51 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 84 33 

clinical_engagement 
diagnosis 
demography 
70 new agents 
343 
disease_progression 
H-positive risk:  662 692 93 1053 386 100 1154 415 153 54 168 70 
H-negative risk:  692 662 1154 1053 415 386 100 93 168 153 70 54 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 82 34 

clinical_engagement 
diagnosis 
demography 
78 new agents 
344 
disease_progression 
H-positive risk:  671 685 93 1063 378 99 1150 414 151 56 171 69 
H-negative risk:  685 671 1150 1063 414 378 99 93 171 151 69 56 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 82 33 

clinical_engagement 
diagnosis 
demography 
76 new agents 
345 
disease_progression 
H-positive risk:  662 691 91 1066 379 99 1147 416 150 59 173 67 
H-negative risk:  691 662 1147 1066 416 379 99 91 173 150 67 59 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 80 33 

clinical_engagement 
diagnosis 
demography 
67 new agents 
346 
disease_progression 
H-positive risk:  661 688 91 1071 382 99 1143 416 150 58 172 69 
H-negative risk:  688 661 1143 1071 416 382 99 91 172 150 69 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 80 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
347 
disease_progression 
H-positive risk:  666 690 94 1066 375 100 1143 410 152 60 173 71 
H-negative risk:  690 666 1143 1066 410 375 100 94 173 152 71 60 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 83 31 

clinical_engagement 
diagnosis 
demography 
64 new agents 
348 
disease_progression 
H-positive risk:  660 695 93 1063 380 101 1143 408 151 62 174 70 
H-negative risk:  695 660 1143 1063 408 380 101 93 174 151 70 62 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 84 30 

clinical_engagement 
diagnosis 
demography 
84 new agents 
349 
disease_progression 
H-positive risk:  659 688 96 1069 378 99 1143 409 156 62 170 71 
H-negative risk:  688 659 1143 1069 409 378 99 96 170 156 71 62 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
69 new agents 
350 
disease_progression 
H-positive risk:  660 691 96 1075 383 96 1140 403 157 63 170 66 
H-negative risk:  691 660 1140 1075 403 383 96 96 170 157 66 63 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 84 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
351 
disease_progression 
H-positive risk:  660 693 99 1074 377 95 1142 400 160 63 170 67 
H-negative risk:  693 660 1142 1074 400 377 95 99 170 160 67 63 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
352 
disease_progression 
H-positive risk:  666 694 97 1071 379 94 1138 399 158 66 173 65 
H-negative risk:  694 666 1138 1071 399 379 94 97 173 158 65 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
353 
disease_progression 
H-positive risk:  664 691 99 1073 379 92 1137 399 160 66 174 66 
H-negative risk:  691 664 1137 1073 399 379 92 99 174 160 66 66 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
354 
disease_progression 
H-positive risk:  668 694 96 1074 379 92 1133 400 162 64 174 64 
H-negative risk:  694 668 1133 1074 400 379 92 96 174 162 64 64 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 82 30 

clinical_engagement 
diagnosis 
demography 
77 new agents 
355 
disease_progression 
H-positive risk:  667 694 98 1085 374 90 1132 400 160 63 171 66 
H-negative risk:  694 667 1132 1085 400 374 90 98 171 160 66 63 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
86 new agents 
356 
disease_progression 
H-positive risk:  674 704 101 1076 366 91 1132 403 157 58 169 69 
H-negative risk:  704 674 1132 1076 403 366 91 101 169 157 69 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
85 new agents 
357 
disease_progression 
H-positive risk:  674 706 102 1070 365 92 1131 415 154 58 166 67 
H-negative risk:  706 674 1131 1070 415 365 92 102 166 154 67 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
94 new agents 
358 
disease_progression 
H-positive risk:  675 704 104 1069 359 97 1135 418 151 55 162 71 
H-negative risk:  704 675 1135 1069 418 359 97 104 162 151 71 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
99 new agents 
359 
disease_progression 
H-positive risk:  676 704 101 1077 354 96 1137 417 150 56 163 69 
H-negative risk:  704 676 1137 1077 417 354 96 101 163 150 69 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
360 
disease_progression 
H-positive risk:  674 707 98 1073 362 98 1137 415 147 56 164 69 
H-negative risk:  707 674 1137 1073 415 362 98 98 164 147 69 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
85 new agents 
Time difference of 15.55247 mins
This is task 8
